BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30085428)

  • 1. The role of OPRM1 polymorphism in the etiology of alcoholism.
    Samochowiec A; Samochowiec J; Pełka-Wysiecka J; Kucharska-Mazur J; Grochans E; Jabłoński M; Bieńkowski P; Murawiec S; Małecka I; Mak M; Kołodziej Ł; Heitzman J; Grzywacz A
    Adv Clin Exp Med; 2019 Feb; 28(2):199-202. PubMed ID: 30085428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of associations of the opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) with alcohol dependence: review and meta-analysis of retrospective controlled studies.
    Kong X; Deng H; Gong S; Alston T; Kong Y; Wang J
    BMC Med Genet; 2017 Oct; 18(1):120. PubMed ID: 29070014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
    Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [μ-Opioid Receptor Gene (OPRM1) Polymorphisms A118G and C17T in Alcohol Dependence: A Turkish Sample].
    Gürel ŞC; Ayhan Y; Karaaslan Ç; Akel H; Karaca RÖ; Babaoğlu MÖ; Yaşar Ü; Bozkurt A; Dilbaz N; Uluğ BD; Demir B
    Turk Psikiyatri Derg; 2016; 27(2):0. PubMed ID: 27370058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the
    Sebold M; Garbusow M; Cerci D; Chen K; Sommer C; Huys QJ; Nebe S; Rapp M; Veer IM; Zimmermann US; Smolka MN; Walter H; Heinz A; Friedel E
    J Psychopharmacol; 2021 May; 35(5):566-578. PubMed ID: 33726538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. μ-Opioid receptor gene (OPRM1) polymorphism A118G: lack of association in Finnish populations with alcohol dependence or alcohol consumption.
    Rouvinen-Lagerström N; Lahti J; Alho H; Kovanen L; Aalto M; Partonen T; Silander K; Sinclair D; Räikkönen K; Eriksson JG; Palotie A; Koskinen S; Saarikoski ST
    Alcohol Alcohol; 2013; 48(5):519-25. PubMed ID: 23729673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis.
    Chamorro AJ; Marcos M; Mirón-Canelo JA; Pastor I; González-Sarmiento R; Laso FJ
    Addict Biol; 2012 May; 17(3):505-12. PubMed ID: 22515274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of ADH1B and OPRM1 alleles predisposing for alcohol consumption are increased in the Hungarian psoriasis population.
    Szentkereszty-Kovács Z; Fiatal S; Szegedi A; Kovács D; Janka E; Herszényi K; Holló P; Nikamo P; Ståhle M; Remenyik É; Törőcsik D
    Arch Dermatol Res; 2019 Aug; 311(6):435-442. PubMed ID: 31011876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OPRM1 A118G and serum β-endorphin interact with sex and digit ratio (2D:4D) to influence risk and course of alcohol dependence.
    Gegenhuber B; Weinland C; Kornhuber J; Mühle C; Lenz B
    Eur Neuropsychopharmacol; 2018 Dec; 28(12):1418-1428. PubMed ID: 30322771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden.
    Bart G; Kreek MJ; Ott J; LaForge KS; Proudnikov D; Pollak L; Heilig M
    Neuropsychopharmacology; 2005 Feb; 30(2):417-22. PubMed ID: 15525999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the OPRM1 A118G polymorphism on alcohol-induced euphoria, risk for alcoholism and the clinical efficacy of naltrexone.
    Setiawan E; Pihl RO; Benkelfat C; Leyton M
    Pharmacogenomics; 2012 Jul; 13(10):1161-72. PubMed ID: 22909206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association studies of dopamine D4 receptor gene exon 3 in patients with alcohol dependence].
    Grzywacz A; Kucharska-Mazur J; Samochowiec J
    Psychiatr Pol; 2008; 42(3):453-61. PubMed ID: 19899572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.
    Schacht JP; Anton RF; Voronin KE; Randall PK; Li X; Henderson S; Myrick H
    Neuropsychopharmacology; 2013 Feb; 38(3):414-22. PubMed ID: 23032071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review and meta-analysis of the moderating effect of rs1799971 in OPRM1, the mu-opioid receptor gene, on response to naltrexone treatment of alcohol use disorder.
    Hartwell EE; Feinn R; Morris PE; Gelernter J; Krystal J; Arias AJ; Hoffman M; Petrakis I; Gueorguieva R; Schacht JP; Oslin D; Anton RF; Kranzler HR
    Addiction; 2020 Aug; 115(8):1426-1437. PubMed ID: 31961981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The OPRM1 A118G polymorphism: converging evidence against associations with alcohol sensitivity and consumption.
    Sloan ME; Klepp TD; Gowin JL; Swan JE; Sun H; Stangl BL; Ramchandani VA
    Neuropsychopharmacology; 2018 Jun; 43(7):1530-1538. PubMed ID: 29497164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OPRM1 genotype and naltrexone response in depressed alcohol-dependent patients.
    Foulds JA; Ton K; Kennedy MA; Adamson SJ; Mulder RT; Sellman JD
    Pharmacogenet Genomics; 2015 May; 25(5):270-3. PubMed ID: 25715171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of mu-opioid receptor gene polymorphism A118G with alcohol dependence in a Japanese population.
    Nishizawa D; Han W; Hasegawa J; Ishida T; Numata Y; Sato T; Kawai A; Ikeda K
    Neuropsychobiology; 2006; 53(3):137-41. PubMed ID: 16679777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family-based and case-control association studies of glutamate receptor GRIK3 Ser310Ala polymorphism in Polish patients and families with alcohol dependence.
    Samochowiec J; Grzywacz A; Kucharska-Mazur J; Samochowiec A; Horodnicki J; Pelka-Wysiecka J; Syrek S
    Neurosci Lett; 2006 Mar; 396(2):159-62. PubMed ID: 16356644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OPRM1 A118G genotype fails to predict the effectiveness of naltrexone treatment for alcohol dependence.
    Coller JK; Cahill S; Edmonds C; Farquharson AL; Longo M; Minniti R; Sullivan T; Somogyi AA; White JM
    Pharmacogenet Genomics; 2011 Dec; 21(12):902-5. PubMed ID: 21946895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence.
    Franke P; Wang T; Nöthen MM; Knapp M; Neidt H; Albrecht S; Jahnes E; Propping P; Maier W
    Am J Med Genet; 2001 Jan; 105(1):114-9. PubMed ID: 11424981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.